U.S. federal trademark · Serial No. 78079609
Liposome encapsulated pharmaceutical preparations delivered via the pulmonary system for the treatment of cancer, auto-immune disorders, emesis, metabolic disorders, rheumatic disorders, heart disease, lung disease, diseases affecting the central nervous system, viral and bacterial infections, sexual dysfunction, infertility, and relief from acute pain, chronic pain, post-surgical pain and cancer-related pain
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.